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In many cases  of  "autolmmune"  hemolytic  disease  (AHD)  the  patient's 
red cells (RBC) are sensitized with autologous 7S ~/-globulln  1 (see reference 2). 
In an effort to gain some insight into the pathogenesis of these autoantibodies, 
studies  on  their  structural  homogeneity  or  heterogeneity  have  been  under- 
taken. Numerous investigations of the homogeneous 3,-globulins produced by 
plasmacyfic tumors (myeloma) in man and mice (see reference 3) have pointed 
to  the  possibility  that  structural  homogeneity  of  a  given population  of  3'- 
globulin molecules may reflect some degree of homogeneity of the  cell popu- 
lation synthesizing  those molecules.  Similar structural  studies  of erythrocyte 
autoanfibodies may contribute  to the  eventual characterization  of their  cells 
of origin. 
The present investigation made use of a simple antigenic marker system. Human 
7S v-globulins appear to be composed of two pairs of dissimilar  polypeptide chains, 
termed  "heavy" (H)  chains  and  "light"  (L)  chains  because of differing  molecular 
weights (4, 5). The L chains have been found to be of two major antigenic types, type 
I and type II, based on their abilities to elicit specific antibodies in rabbits (6-10). Evi- 
dence has been adduced that a given 7-globulin molecule carries L chains of either type 
I or type II (9, 10). The serum 7S "y-globulins of healthy donors have been found to con- 
rain molecules having type I or type II L chains in roughly a 2:1 ratio, respectively 
(9, 10). A given lymphoid cell appears to synthesize either type I or type II ~/-globulins, 
or perhaps both types very rarely (11). Isolated antibodies to a given antigen made by 
a normal individual have been reported to include molecules of both L chain types, al- 
though the ratio of type I to type II molecules may deviate greatly from the 2:1 ratio 
in the individual's whole serum (12, 13). By contrast, myeloma globulins in the serum 
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x  These autoreactive ~,-globulins  will subsequently be termed "erythrocyte autoantibodies" 
for ease of reference. 
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of a given patient are composed exclusively of molecules having either type I  or type 
II L chains (7, 8). 
This  report  will present  evidence  that  populations of  isolated  erythrocyte 
autoanfibodies  exhibit  a  strikingly high  frequency  of  L  chain homogeneity. 
Some of these  autoantibody populations bearing only one detectable L  chain 
type may also display relative homogeneity in electrophoretic mobility. 
Materials and Methods 
Human  Antibodies.--For  isolation of autoantibodies, bleedings from patients  2 were taken 
into 0.01 M Na2EDTA or ACD solution,  a Eluates from 6 times washed  RBC stromata were 
made by acidification  (14) or by heating at 60°C for 30 minutes.  8 Anfi-Rho antibodies (anti-D) 
(anti-Rhl) (15) from individual donor sera  4 were reacted at 37°C with the 6 times washed 
RBC of a healthy donor whose phenotype was O R_ho (ccDee)  (Rh: 1,  --2, --3, 4, 5)  (15). 
Eluates from the washed, sensitized RBC were made by acidification. These eluates displayed 
no reactivity with Orh (ccddee)  (Rh: --1, --2, --3, 4, 5) RBC. None of the Rh antisera or 
elnates contained demonstrable saline agglutinating activity for O Rho  RBC.  Autoantibody 
and  Rh  antibody eluates  were  concentrated  by negative pressure  ultrafiltration through 
collodion  membranes. The  only immunoglobulin detectable by hemagglutination and im- 
munodiffusion in the concentrated eluates was 7S 5'-globulin. 5 
Antigens.--Bence  Jones (B  J) proteins, the pathologic equivalent of normal L  chains (16), 
were isolated from urines of myeloma patients, Sm. (type I) and S1. (type II), by precipitation 
in 55 per cent saturated ammonium sulfate followed by chromatography on DEAE cellulose 
(17).  Highly purified  7S myeloma globulins were  obtained by utilizing their properties as 
euglobulins or cryoglobulius. The original typing of BJ and myeloma proteins was established 
by Ouchterlony analyses employing reference  BJ proteins kindly supplied by Dr. Leonhard 
Korngold (6). 
Antisera.--Anti-Bence  Jones sera (anti-B J) were  made in rabbits by immunization with 
the Sin. or S1. BJ protein in complete Freund's adjuvant, followed by intravenous administra- 
tion of alum precipitates. The resulting antisera were absorbed in small increments with BJ 
protein and isolated 7S myeloma globulin of the opposite  type, and finally with the fast frag- 
ment of normal human 7S "),-globulin  prepared by published methods (18, 19). In Ouchterlony 
analysis the absorbed antisera gave a  single precipitin line with Cohn Fr. II, and this line 
fused  completely with the lines given by several BJ proteins and myeloma globulins of the 
corresponding type and with the line given by L  chains obtained from normal q/-giobulin 
(20). No precipifin lines were detected against a wide range of concentrations of the following 
antigens: BJ proteins and myeloma globulins of the opposite  type, the fast fragment from 
normal "y-globulin, and the urinary "H  chains" of Franklin's patient, Cr.  (21).  s Anti-7S 
2 We are indebted to the following physicians for allowing us to study their patients: Dr. 
Scott N. Swisher, Dr.  Stanley B. Troup, and Dr. James Carlin, Rochester,  New York; Dr. 
John H. Crookston and Dr. Richard C. Hasselback,  Toronto, Canada; Dr. Ben Fisher, Buf- 
falo; Dr. Allyn Judd, Delray Beach, Florida; Dr. Russell Weisman, Jr. and Dr. Samuel Gross, 
Cleveland; Dr.Richard Platzer, Clifton Springs,  New York; Dr. Nathan A. Cohen and Dr. 
Kenneth Ho, Syracuse,  New York.  We are further indebted to Dr. Swisher for the generous 
donation of previously made eluates on patients St., Th., Se., Ka., Tr.(a), and Coo. 
a Collection of blood in acid citrate dextrose  solution (ACD) and elution by heating were 
the procedures  used in the preparation of the elnates obtained from Dr. Swisher. 
4 Two of these anti-Rho sera were kindly donated by Dr. John H. Crookston. 
5 Synonyms of 7S ^/-globulin are q/2-globulin and 5"Bs-globulin. 
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"y-globulin (antl-TS),  prepared by intravenous immunization of rabbits with  Cohn Fr. IIl.l 
precipitated in alum, contained precipitating antibodies to the H chains of 7S 7-globulin and 
to both types of L chains. Antiserum to the H chains of 7S "y-globulin (anti-H'y2) was prepared 
by absorbing anti-TS serum with isolated normal human L chains (20). This antiserum reacted 
with the H chain portions of both fast and slow fragments of human 7S 3,-globulin.  Antisera 
specific for the fast fragment of 7S 3,-globulin (anti-F72), for 71A (flcA)-globulin,  for TIM 
TABLE I 
Specificity  of the Anti-BJ Sera in Hemagglutination 
Resultin~ 
RBC sensitized  by  Antiserum used in antiglobulin  reaction  agglutinatton 
(titer) 
Ri. anti-Rho serum 
Ri. anti-Rh, serum 
BDB-myeloma IH 
BDB-myeloma IIIl 
BDB-normal 7SH 
Anti-BJx  +  saline 
Anti-BJi  +  L chains* 
Anti-BJi  +  BJI§ 
Anti-BJi  +  BJII§ 
Anti-BJi  +  H chains§ 
Anti-BJH +  saline 
Anti-BJii +  L chains* 
Anti-BJIt +  BJx§ 
Anti-BJii +  BJII§ 
Anti-BJH +  H chains§ 
Anti-BJi 
Anti-BJi  I 
Anti-7S 
Anti-BJi 
Anti-BJ  I t 
Anti-7S 
AntioBJi 
Anti-BJ  i t 
Anti-7S 
>160 
o, 
0 
>160 
>160 
>160 
0 
>160 
0 
>160 
80 
0 
1280 
0 
40-80 
1280 
++ 
++ 
++++ 
* 40/~g N/ml final concentration. 
:~ Zero (0) indicates no reaction with 1/10 dilution of antiserum. 
§ 20 #g N/ml final concentration. 
]I 250 #g N/ml of isolated type I or II myeloma globulins, or Cohn Ft. II. 
(flvM)-globulin  and for the tiC-iliA-globulin  component of complement (anti-C') have been 
described in detail elsewhere (22). All antisera were thoroughly absorbed with normal human 
RBC of each major blood group prior to use in antiglobulin reactions. 
Confirmation of the specificity of each anti-BJ serum was obtained by: (o) PCA reactions 
(23) in which isolated type I and type II myeloma globulins were the challenging antigens; 
(b) antiglobulin reactions with RBC coated with either type I or type II myeioma globulin 
by bisdiazotized benzidine (BDB)  (24); and  (c)  specific blocking of antiglobulin reactions 
against RBC sensitized by Rh antibody. The latter two methods are illustrated in Table I. 
Specific hemagghitination inhibition  was produced by the homologous BJ protein or normal HUMAN ERYTHROCYTE AUTOANTIBODIES. I 
L chains (20) but not by the opposite  BJ protein or H chains (Cr.).  With the BDB method 
each  anti-BJ serum agglutinated only those  RBC  coated  with  the  appropriate  myeloma 
globulin. 
Hemagglutinat¢on Methods.--Prelinfinary  tests were carried out to determine the optimum 
dilution of the eluted, concentrated autoantibodies to effect maximum sensitization without 
producing non-specific  clumping of RBC.  Although the autoantibodies reacted with every 
donor cell tested, the group O rh (ceddee) RBC of a single healthy donor were chosen as the 
standard test cells. The group O Rho (ccDee) RBC previously mentioned were employed for 
testing anti-Rho antibodies. In all cases sensitization was carried out at 37°C for 1 hour, fol- 
lowed  by antiglohnlin (Coombs)  testing,  (see reference  25 for details). Genetically deleted 
RBC, with the phenotypes O -D-/-D- (ttendsbee) and A --/-- (MackaU), were generously 
donated by Dr.  Philip Levine. These RBC  had  been glycerolized  and stored  at  -50°C. 
Reconstitution of the cells for indirect antiglobuhn reactions was by the method of Weiner 
(26). 
Ouchterlony Diffusion  and Immunoelectrophoresis.--Radial  double diffusion reactions were 
carried out on microscope slides using 1 per cent agar in pH 7.3 phosphate-buffered saline (27). 
Immunoelectrophoresis was also performed  on microscope slides with 1 per cent agar in 0.03 
barbital, pH 8.2 (28). 
Quantitative Measurement of  Type I  and  Type II  "y-Globulins.--Using the quantitative 
Oudin technique (29, 30), as modified by Dr. John H. Vaughan (31), 7S T-globulins chroma- 
tographically isolated (17) from the sera of normal subjects and AHD patients were allowed 
to diffuse against the anti-BJ sera.  The actual concentrations of a given T-globulin type in 
unknown samples  were  derived from a  standard plot of analogous values obtained with a 
human 7S T-globulin  pool (Cohn Fr. II, Squibb lot 1967, E. R. Squibb and Sons, New York) 
This pool was assumed to contain type I  and type II molecules in a 2:1 ratio (9, 10). 
RESULTS 
The  RBC  of  20  patients  with  "autoimmune"  hemolytic  disease  (AHD) 
gave moderate  to strong direct antiglobulin (Coombs)  reactions with an anti- 
serum to whole 7S ~/-globulin (anti-7S) and with an antiserum specific for the 
fast fragment of 7S "),-globulin (anti-F~2). The RBC of 9  of the 16 patients so 
tested  were  also  agglutinated  by  an  anti-C'  serum  (anti-13xC-A-globulin).  7 
None of the  RBC  samples was  agglutinated by specific anti-q,  xA-globulin or 
anti--~,xM-globulin sera. The anti-BJ sera gave negative reactions or equivocal 
typing patterns  with  all RBC  samples  tested  in these  direct  antiglobulin re- 
actions, despite many strong reactions with the anti-7S and anti-F~,2-sera. 
L  Chain  Typing.-- 
Indirect  antiglobulin  reaction: 
For comparison to the above results, RBC sensitized  in t~itro by a  commercial antiRho 
(anti-D) serum were tested with the same rabbit antisera. Heavily sensitized RBC's were ag- 
glutinated not only by anti-7S and anti-Fqt2 sera, but also by both aati-BJ sera. Weaker sensi- 
tization with more diluted Rh antibody gave either no L chain typing, or a false type I "mono- 
7 The presence  of bound complement (C') components on the RBC of many of our AHD 
patients has not caused any evident difficulty in eluting the antibody or in subsequently 
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typic" pattern. Therefore, in typing L chains of either iso- or autoantibodies by hemagglutina- 
tion, we relied upon in vitro sensitization of normal RBC, the intensity of which could be con- 
trolled and made fairly uniform as judged from hemagglutination results with anti-7S serum. 
Every effort was made to sensitize the test cells maximally, short of causing non-specific ag- 
glutinability. 
When normal RBC were heavily sensitized in vitro with the autoantibody 
eluates from patients with AHD, a  spectrum of reactivities with the anti-BJ 
sera was observed (Table II). The autoantibodies  of 8 patients reacted only 
with  anti-BJ~  (monotypic  s  type  I).  Those  of  4  patients  reacted  only  with 
anti-BJii (monotypic  8 type II). Those of 7 patients reacted with both antisera 
(bitypic).  In the latter  group,  the  eluates of El.,  Be.,  and No.  showed very 
little reactivity with anti-BJm while the eluate of He. showed only slight re- 
activity with anti-BJi. 
In addition  to  the  19  autoantibody eluates just  described,  2  eluates from 
another AHD patient,  Tr.,  separated  by an  interval  of more than  9  years, 
were of special interest.  The earlier eluate,  representing a  concentrated pool 
of several eluates obtained between  1950  and  1955,  gave reactions with both 
anti-BJ sera, with the anti-BJi reaction  predominating [Tr.  (a), Table H]. A 
recent eluate,  of approximately equal strength as judged from hemagglutina- 
tion with anti-TS, reacted only with anti-B]I [Tr. (b), Table II].  9 
Also  recorded  in  Table II are  reactions  of RBC  sensitized  by 6  anti-Rho 
(anti-D)  sera  from  donors  without  known  hematologic  disease.  In  5  cases 
agglutination was clearly positive with both anti-BJ sera. Red cells sensitized 
by Gu. serum, however, consistently failed to react with the anti-BJH serum, 
despite levels of RBC sensitization  apparently comparable to those achieved 
with  the  other  anti-Rho sera.  When  RBC  were sensitized  with  isolated anti- 
Rho antibodies from donors Ri., Bl., Ja., and Gu., obtained by the same acid 
elution  and concentration  techniques used for the autoantibodies,  the results 
were essentially the same as those observed with RBC sensitized by the native 
sera (Table II). 
Anti-Rho antibodies were present in the serum of AHD patient Tr. because 
of a  previous incompatible transfusion.  Both  in native serum and when iso- 
lated by elution,  these isoantibodies gave a  bitypic pattern,  with type I  pre- 
dominating,  at a  time when  only type I  L  chains  could be identified  in the 
patient's autoantibody eluate,  Tr.  (b).  No free autoantibody  was detectable 
in her serum in tests with O rh red cells. 
s For convenience the term "monotypic" will be applied to eluates reacting with only one 
of the  two anti-BJ  sera. It is recognized, however, that these hemagglutination methods, 
although sensitive, might fail to detect a very minor population of molecules of the opposite 
type. 
9 Although the earlier Tr. eluates, Tr.  (a), were made by heating, while the recent Tr. 
eluate, Tr.  (b), was obtained by acidification, there is no apparent reason to attribute  the 
differences in the Tr. eluates to the elution methods (of. Discussion). 6  HUMAN  ERYTHROCYTE  AUTOANTLBODIES.  I 
TABLE  II 
Summary  of L  Chain Typing  by Hemagglutina~ion 
NorraalRBCsensitized by 
Antiglobulin reactions (titers) 
Anti-  Anti-  BJI  BJII  Anti-7S* 
AHD autoantibodies 
Fr. (55 M)§.  320  011  5120 
Re. (57 M)  320  0  2560 
Mo. (79 M).  160-320  0  5120 
Con. (68 F)  160  0  5120 
St. (63 M)  160  0  2560 
Ma. (66 M)  160  0  5120 
Ka.  (59 F)  160  0  2560 
Th. (88 F)  80  0  5120 
El. (19 M)  160  5  5120 
Be. (75 F).  160  5  5120 
No.  (30 F)  320  20  5120 
Tr.  (53 F) (a) (1950-55)..  640  80  5120 
....  (b) (1964) .....  320  0  2560 
Coo.  (22 F).  160  160  2560 
Me. (36 M)  320  320  2560 
Po. (39 F).  40  320  5120 
He. (25 M).  20  640  >5120 
Se. (77 M)  0  >80  >1280 
Sa. (64 F)..  0  160  2560 
Ad. (73 M)  0  320  5120 
De. (56 F).  0  640  >5120 
Rh isoantibodies 
Ri. serum.  640  640  2560 
"  eluate.  > 160  160  > 160 
BI. serum..  320  640  5120 
"  eluate..  320  640  5120 
Ja. serum  320  80  5120 
"  eluate  640  40  5120 
Gu. serum..  160  0  5120 
"  eluate..  640  0  5120 
Ro. serum  640  80  5120 
Gi.  "  320  80-160  5120 
Tr.  "  (1964)**.  160  40  2560 
"  eluate  (" )  320  40  5120 
Kno~rn 
duration of 
positive 
Coombs' test:[: 
Recognized 
associated disease 
21 mos. 
4 yrs. 
9 mos. 
1  " 
1  " 
1  " 
6  " 
2  " 
6 yrs. 
2 mos. 
6 yrs. 
1-5  " 
14  " 
2  " 
5  " 
10  " 
13  " 
10 mos, 
14  " 
2  cc 
6 yrs. 
None 
CLL¶ 
~c 
None 
~c 
Hodgkin's 
None 
lc 
gc 
cg 
gc 
~c 
Ca. lung 
Lymphosarcoma 
None 
* Anti-F'yz gave very comparable results, not shown. 
Duration prior to bleeding for isolation of autoantibodies. 
§ (Age at onset, sex). 
II Zero (0) indicates no reaction with 1/5 dilution of antiserum. 
¶  CLL, chronic lymphocytic leukemia. 
** AHD patient Tr. JOHN  P.  LEDDY  AND  RICHARD  :F.  BAKEMEIER 
Fic. 1.  Double  diffusion  (Ouchterlony)  analyses  of isolated  erythrocyte autoantibodies. 
Center  wells:  Ft.,  Re.,  Ad.,  De.,  Po.,  and  Tr.(a)  concentrated  eluates.  Anti-l,  anti-BJ1; 
anti-H, anti-B[ii. MI, MII; isolated type I and type II myeloma globulins, respectively. 
Gel  precipitin  reaclions:  By  means  of  Ouchterlony  gel  precipitin  reactions 
the  L  chain  typing  was  confirmed  for  those  7  autoantibody  eluates  having 
sufficient "y-globulin concentration  to permit this analysis (Fig.  1). For example, 
the eluates  of patients  Fr.  (Fig.  1 a  and c),  Re.  (Fig.  1 b) and  Mo.  (not shown) HUMAN  ERYTHROCYTE  AUTOANTIBODIES.  I 
gave a  precipitin  line only with anti-BJi,  and this line fused completely with 
that  of a  known type I  myeloma globulin.  With  the  eluates  of patients  Ad. 
(Fig. 1 c) and De.  (Fig. 1 d)  a  precipitin  line was produced only by anti-BJn, 
fusing  with  the  line  of a  known type  II myeloma globulin.  In contrast,  the 
autoantibodies  of patient  Po.  (Fig. 1 e)  and Tr.  (a)  (Fig. 1 f) gave strong pre- 
cipitin  lines with  both  antisera.  Isolated Rh antibodies  from donors Ri.  and 
B1. also gave precipitin reactions with both antisera  (not shown). 
TABLE III 
Type I and Type II Serum 7S "y-Globulins  from AHD Patients and Normal Donors 
Patient (autoantibody type) 
Fr. (I) ......................... 
Re. (I) ......................... 
Con. (I) ...................... 
De. (II) ....................... 
Se. (II) ....................... 
Sa. (II) ....................... 
Ad. (II) ....................... 
Po. (ii >  i) ................... 
Tr. (a) (I >  II) ................ 
Tr. (b) (I) ..................... 
Total* 
188 
102 
95 
110 
95 
118 
108 
133 
97 
84 
7S 3,-globulin (og N/ml of serum fraction) 
Type I~;  Type IH: 
132  83 
68  41 
57  39 
73  42 
73  36 
73  56 
85  38 
84  44 
71  38 
61  30 
80  40 
Type I/Type II 
1.58 
1.67 
1.44 
1.73 
2.05 
1.32 
2.22 
1.89 
1.89 
2.05 
10 Normals, Mean  (=1=2 SD) ......  110  2.00 
(4-0.76) 
* Analyzed with anti-H3'._, serum  see Materials and Methods). 
~: Analyzed with corresponding anti-BJ serum. 
Overall Production of Type I  and Type II  7S 3,-Globulins.--The quantitative 
Oudin technique was used to determine  the relative proportions of type I  and 
type II molecules in 7S ~,-globulin fractions from the sera of 10 AHD patients 
and  10 normal persons. Despite the restricted  representation  of L  chain types 
in  many  of  the  autoantibody  populations,  all  of  the  AHD  patients  showed 
ratios  of type I:type II 7S 3,-globulins which fell within  two standard devia- 
tions of the normal mean (Table III). 
A utoantibody  Specificity.--Because the inclusion of multiple combining speci- 
ficities in a  given autoanfibody population might contribute  to heterogeneity 
in its L  chain types (see Discussion), selected testing of 12 eluates was carried 
out with genetically "deleted" RBC (32, 33).  From Table IV it is evident that 
differences  in  specificity  among  these  autoantibodies  can  be  detected.  One 
eluate  (De.)  reacted with normal RBC but not with either deleted cell. Three 
other  eluates  reacted  with  normal  and  -D-/-D-  (partially  deleted)  cells,  but JOHN  P.  LEDDY  AND  RICHARD  F.  BAKEMIEIER 
not with the ---/--- (fully deleted) cells. Many reacted with all 3 test ceils. The 
last  pattern  has  been shown  (33)  to result  from the presence  of  antibodies 
reactive with  1,  2,  or all 3 of the test cells, as determined by the capacity of 
each cell type to absorb all or part of the total reactivity of the eluate. After 
absorption with ---/--- cells neither the monotypic eluate of Ad. nor the bitypic 
eluate  of Po.  showed any residual  reactivity with  the other  test cells  (Table 
IV). The supply of deleted cells was insufficient for further absorption studies. 
TABLE IV 
A ntiglobulin Reactions of Deleted RBC Sensitized by A utoantibodies 
Eluate  from patient: 
Fr ......................... 
Re ......................... 
Mo  ......  ~ ................. 
Con  ........................ 
De  ......................... 
Sa ......................... 
Ad  ......................... 
Po .......................... 
Coo  ......................... 
Tr. (a) ...................... 
No  .......................... 
E1 .......................... 
Ad. absorbed* ............... 
Po. absorbed*  ................ 
L  chain(s) 
detected 
II 
II 
II 
II>I 
I~---II 
I  >II 
I>>II 
I>> II 
Normal 
++ 
++ 
++ 
+++ 
+++ 
++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
RBC  used  for testing 
-D-/-D- 
+++ 
+ 
+ 
+++ 
0 
++ 
+++ 
+++ 
++ 
+++ 
+++ 
++ 
___/.__ 
++ 
+++ 
+ 
0 
0 
0 
+++ 
+++ 
+++ 
+++ 
+++ 
0 
* Eluate, in suitable dilution, absorbed once at 37°C with  1/3 volume of packed ---/--- 
RBC. Absorptions were also carried out with -D-/-D- RBC, with similar results. 
Electrophoretic  Dispersion.--It  was  of interest  to  determine whether  auto- 
antibody populations showing only one L  chain type would also be relatively 
homogeneous  in  their  physical  properties  as  compared  to  bit333ic  autoanti- 
bodies and isoantibodies. In Fig. 2 are shown irnmunoelectrophoretic patterns 
given  by  highly  concentrated  preparations  of  these  antibodies  with  anti-7S 
serum. The autoantibody populations of patients  Fr.  (monotypic type I) and 
Ad. (monotypic type II) were relatively homogeneous electrophoreticaUy (Fig. 
2 a  to c), closely resembling patterns observed with myeloma globulins  (Fig. 
2 b). On the other hand, the type I  eluates of patients Re. and Tr. (b)  showed 
greater electrophoretic dispersion  (Fig.  2 d and e) approaching, but not quite 
equaling,  that of normal 7S 5'-globulins. The latter pattern was also observed 10  HUMAN  ERYTHROCYTE  AUTOANTIBODIES.  I 
FIG. 2.  Immunoelectrophoretic  behavior  of  isolated  autoantibodies  and  Rh  antibodies. 
(a)  and  (b): Autoantibodies of patient Fr.  compared to Cohn Fr.  II  (HGG)  and  to isolated 
7S  myeloma globulin.  (c)  through  (f):  Autoantibodies of patients Ad.,  Re., Tr.(b)  and  Po. 
compared  to  autologous  serum  or  to  Cohn  Ft.  1I.  (g)  and  (1l): Ri.  and  B1.  Rh  antibodies 
compared to autologous serum. The patterns were developed with anti-7S serum. The eathodal 
extensions of the precipitin lines given by Po., Ri., and BI. eluates were more clearly visualized 
on the original plates. JOHN  P.  LEDDY  AND  RICHARD  ]L  BAKEMEIER  11 
with the bitypic eluate of patient Po. (Fig.  2 f) and with the isolated Rh anti- 
bodies from donor Ri. (Fig. 2 g). Isolated Rh antibodies from B1. may be some- 
what less polydisperse (Fig.  2 h)  than  those from Ri. Insufficient monotypic 
Gu. anti-Rho eluate is available at present for electrophoresis. 
DISCUSSION 
L Chain Types.--Isolated populations of normal human antibodies (12, 13) 
and of several types of "autoantibodies" (12,  13, 34, 35) have generally been 
found to be composed of both type I and type II T-globulins,  often with mod- 
erate predominance of type I. This is in keeping with the normal predominance 
of this type in human serum (9, I0). In contrast, a majority of the erythrocyte 
autoantibody populations  examined  in  the present  study were found  to  be 
remarkably homogeneous in  their L  chain  content,  exhibiting,  by the  tech- 
niques employed, L  chains of entirely one type (12 cases)  or with a marked 
predominance of one type (4 additional cases).  An especially striking contrast 
to the latter finding  is provided by the clearly demonstrated L  chain hetero- 
geneity of 17 of 18 populations of 7S anti-Rho  (anti-D)  antibodies studied to 
date  (references  12,  13 and  Table I1).  In fact,  the anti-Rho isoantibodies of 
AHD patient Tr. contained 3"-globulins of both types, even though the auto- 
antibody eluate prepared from the same bleeding,  Tr. (b), displayed only type 
I  L  chains  (Table II). The finding  of 4 autoantibody populations apparently 
composed entirely of type II ")'-globulins is particularly striking.  Since roughly 
only one-third of the serum 7S T-globulins  of these patients are type II (Table 
III; references  9,  10), these autoantibodies fall within a minority population 
of the patients' total serum 3,-globulins. Evidence for relative L chain homo- 
geneity of erythrocyte autoantibodies, with type II predominating,  has also 
been presented by Franklin  and  Fudenberg in 2 of 3 AHD patients studied 
by direct antiglobulin tests (13). 
Erythrocyte autoantibodies are not unique  in  exhibiting  apparently  com- 
plete  or  relative  L  chain  homogeneity.  Pathologic  cold hemagglutinins  and 
certain rheumatoid factors have been found to contain a single L  chain type 
(12, 13, 36). It must also be pointed out that certain normal antibody popula- 
tions have displayed a marked predominance of type I  or type II molecules, 
although both types were detected (12). 
The  restricted  L  chain  representation  found  in  many  of the  erythrocyte 
autoantibodies in  this  study cannot  be ascribed to a  more general  inability 
to synthesize L  chains  of the opposite type or to incorporate  them into  7S 
molecules (Table III).  It appears likely, therefore,  that  autoantibody popu- 
lations with a high degree of L chain homogeneity reflect some selective effect 
in their synthesis. Possibly they are produced by sharply restricted populations 
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with rare exceptions, a given lymphoid cell contains L chain determinants of 
only one type (11). 
According to current concepts  of antibody formation, one might conceive 
of monotypic antibody populations arising in at least four circumstances.  One 
such circumstance  might be exceptional structural simplicity of the antigenic 
determinant eliciting  the  antibody response,  as  in  chemical  haptens.  Very 
little is known, however, about the structural nature of the RBC determinants 
with which  these  autoantibodies react. Secondly, monotypic antibody popu- 
lations might occur during the earlier stages  of immunization. The duration 
of known erythrocyte autosensitization prior  to  this  study, in  the patients 
with monotypic autoantibodies, varied from 1 month to several years (Table 
II).  Noteworthy are patients Re.  and De.  whose autoantibody populations 
were monotypic despite durations of disease which were at least 4 and 6 years, 
respectively.  Patient  Tr.  demonstrated an  autoantibody population  which 
was monotypic after a  14 year duration, whereas it had been bitypic during 
the earlier years of her disease. Thirdly,  one might postulate a necessary rela- 
tionship between antibody specificity and L chain type. From Table IV, how- 
ever, it is evident that among autoantibodies of a given L  chain type  there 
was no consistent pattern of reactivity with the genetically "deleted" ceils. For 
example, the type II autoantibodies of De., Ad., and Sa. each clearly differed 
in these  tests.  Finally,  a  monotypic autoantibody population might be  the 
product of a clone of cells which had escaped homeostatic controls  (37). It is 
noted that the patients with monotypic autoantibodies included all 4 cases of 
chronic lymphocytic leukemia and the case of lymphosarcoma studied. L chain 
homogeneity in  autoantibodies,  however,  may not  necessarily  imply  their 
formation by pathologic  mechanisms.  The apparent L  chain homogeneity of 
the anti-Rho antibodies  from normal donor Gu. emphasizes the need to know 
the full spectrum of normal  antibody responses  in man before  the L  chain 
homogeneity of these autoantibodies can be placed in proper perspective. 1° 
Because of the obvious limitations on interpreting homogeneity in such  a 
simple  two category system as  the L  chain types provide,  other criteria  of 
structural homogeneity, particularly other antigenic marker systems, are being 
applied to erythrocyte autoantibodies. 
Table II also shows examples of autoantibody populations containing both 
type I  and type II ~,-globulins. The reasons  for clearly bitypic responses in 
some AHD patients, as opposed to the monotypic responses in others,  are not 
apparent.  There is no obvious correlation  with clinical diagnosis  (Table  II). 
Monotypic patterns were encountered  both in idiopathic AHD and in cases 
associated  with malignancy. The cases with clearly bitypic patterns are cur- 
rently considered idiopathic.  As a group,  the patients with bitypic responses 
10 Donor Gu.  is a  36-year-old female with rheumatic heart disease, but with no apparent 
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have  had  recognized erythrocyte autosensitization  for a  longer  time  (Table 
II). The groups are small,  however, and determination of the date of onset of 
autosensitization may be difficult  in retrospect.  Any contribution  of bitypic 
isoantibodies to the L chain typing of these autoantibodies is  unlikely because 
the long intervals between blood transfusions and subsequent bleedings  to ob- 
tain  the  eluates  virtually  eliminated  any  possibility  of  isosensitized  donor 
RBC in these bleedings. 
A possible explanation for the development of more heterogeneous (bitypic) 
autoantibody populations is the inclusion  of 2 (or more) serologic specificities, 
with antibodies of each specificity carrying  a  different type of L  chain.  To 
investigate this point, the studies with genetically"deleted" RBC were initiated. 
The results to date confirm,  first of all, the findings of Weiner and Vos (33) that 
such autoantibodies, which appear to be "pan-antibodies" on testing with ordi- 
nary RBC panels, may indeed show apparent specificity when tested with RBC 
deficient in the serologic expression of Rh antigens. No difference in specificities 
was found with these cells, however, between the clearly bitypic eluate of Po. and 
the monotypic type II eluate of Ad. (Table IV). Both reacted with all the test 
cells and were fully absorbed by the fully deleted (---/---) cells. In the Weiner- 
Vos scheme,  therefore, these eluates might both be judged to have the same 
single  specificity.  The  possibility,  however,  that  reactivity with  ---/--  cells 
could represent multiple specificities is recognized.  One can only conclude that 
differences  in specificity between these two antibody populations of different 
L  chain content cannot be demonstrated in the test systems presently avail- 
able. 
Finally, one cannot exclude the possibility that a single cell line might pro- 
duce autoantibodies of both L chain types. Of possible relevance,  but perhaps 
too early to evaluate, are (a)  the rare cases of myeloma associated with BJ 
and serum myeloma proteins of different L chain  types (7, 38)  and (b) the 1 
to 3 per cent of normal lymphoid cells which might have contained both types 
of ~-globulins in the experiments of Bernier and Cebra (11). 
There is no apparent reason to suspect that  the elution and concentration 
procedures employed in this study prejudiced the L chain typing of the anti- 
bodies. All 3 possible L chain patterns were found in our AHD cases, and there 
was complete agreement in L  chain typing of Rh antibodies derived directly 
from  native  serum  and  from  eluates.  Autoantibody eluates made by the  2 
elution methods gave comparable results (patient De.). 
"Incomplete"  anti-Rho  isoantibodies  from  6  individual  donors  without 
known hematologic disease were chosen for parallel studies as normal antibody 
controls,  for several reasons.  First,  like the autoantibodies under  study, the 
Rh antibodies are 7S ~,-globulins (see Materials and Methods) with maximum 
serologic activity at 37°C and with similar  elution properties. Secondly,  there 
is now mounting  evidence implicating  components of the Rh complex as de- 14  HUMAN  ER~T~OCYTE  AUTOANTIBODIES.  I 
terminants for many RBC autoantibodies of the 7S  class (33).  Finally,  from 
earlier  observations (12), the known bitypic nature of Rh antibodies provided 
a valuable positive control. 
Electrophoretic Dispersion.--The  immunoelectrophoretic  data  accumulated 
to the present (Fig.  2) indicate that relative electrophoretic homogeneity may 
or may not be associated with L  chain homogeneity in a given autoantibody 
population. Repeated observations of Ouchterlony reactions involving all the 
eluates shown in Fig. 2 did not suggest that differences in "g-globulin concen- 
tration were sufficient to account for the observed differences in electrophoretic 
dispersion.  The autoantibodies of Fr., Re., and Po. and the anti-Rho antibodies 
of BI. (Fig.  2) showed rather rapid electrophoretic mobility. The slow mobility 
of 7S "g-globulin in the eluate from patient  Ad.  suggests,  however, that  the 
elution procedure was not responsible  for selecting  populations  of molecules 
with  faster  mobilities  and  thereby  creating  spurious  electrophoretic  homo- 
geneity. 
It is conceivable that the "monotypic" but electrophoretically polydisperse 
autoantibodies  originate  from two or more cell lines  producing,  perhaps  by 
chance,  L chains  of the same type. It  should be noted that certain  antibodies 
made by normal  individuals to selected antigens, such as dextran, may show 
some restriction of electrophoretic dispersion  as compared to the whole serum 
"g-globulin population (39; see also reference 40). 
Erythrocyte autoantibodies may thus possess varying degrees of structural 
similarity to "paraproteins."  This relative homogeneity of structure  appeam 
to be more frequently encountered or more marked in populations of erythro- 
cyte autoantibodies than  among  the anti-Rho  and  other  "normal"  antibody 
populations  so far  examined.  Elucidation  of the possible relevance  of these 
findings to the pathogenesis of AHD will require further study. 
SUMMARY 
The  7S  "g-globulins causing  erythrocyte  autosensitization  in  20  patients 
were  isolated by elution and  examined for homogeneity or heterogeneity of 
their L  chain  types and  electrophoretic dispersion.  The isolated erythrocyte 
autoantibodies  from  12  patients  contained  only  1 detectable L  chain  type. 
Two of these "monotypic" populations showed appreciable restriction of elec- 
trophoretic dispersion, while 2 others more nearly resembled the electrophoretic 
heterogeneity  of  normal  "g-globulins. The  autoantibodies  from  the  other  8 
patients exhibited L chains of both types. The single "bitypic" population so 
tested was relatively polydisperse electrophoretically. As a  comparison, anti- 
Rho  isoantibodies from  5  of  6 donors  without  known  hematologic  disease 
showed bitypic reactions,  and  2 of these isoantibody populations were rela- 
tively polydisperse electrophoretically. One Rh isoantibody is described which 
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The structural  similarities to "paraproteh~s"  observed in a  significant pro- 
portion of these erythrocyte autoantibodies raise the possibility of their origin 
from a  restricted population of antibody forming cells, and may have impli- 
cations concerning the pathogenesis of erythrocyte autosensitization. 
The authors wish to express their indebtedness to Dr. John H. Vaughan for his sustaining 
encouragement and  invaluable advice throughout  the  course of this  study.  Dr.  Scott N. 
Swisher also made many valuable contributions to the development of the work. 
The able technical assistance of Barbara  Moyer and Janet Stone is gratefully acknowl- 
edged. Norma Trabold, William Marchetti,  and Frank  Buettner also assisted with certain 
phases of the work. 
BIBLIOGRAPHY 
1.  Leddy, J. P., and Bakemeier, R. F., The L-chain types of erythrocyte autoanti- 
bodies, J. Clin. Inv., 1954, 43, 1300 (abstract). 
2.  Dacie, J. V., The Haemolytic Anaemias.  Part II. The Autoimmune Haemolyfic 
Anaemias, New York, Grune and Stratton, 2nd edition,  1962. 
3.  Fahey, J. L., Heterogeneity of "y-globulins, Advances Ir,  tmunol., 1962, 2, 41. 
4.  Edelman, G. M., and Poulik, M. D., Studies on structural units of the ~,-globulins, 
J. Exp. Med., 1961,113, 861. 
5.  Porter, R. R., The structure of gamma-globulin and antibodies, in Symposium on 
Basic Problems in Neoplastic Disease, (A. Gellhorn, and E. Hirschberg, editors), 
New York, Columbia University Press, 1962, 177. 
6.  Korngold, L., and Lipari, R., Multiple-myeloma proteins. III. The antigenic rela- 
tionship  of  Bence  Jones  proteins  to  normal  gamma-globulin and  multiple- 
myeloma serum proteins, Cancer, 1956, 9, 262. 
7.  Mannik, M., and Kunkel, H. G., Classification of myeloma proteins, Bence Jones 
proteins, and macroglobulins into two groups on the basis of common antigenic 
characters, 3". Exp. Med., 1962, 116, 859. 
8.  Fahey, J. L., and Solomon, A., Two types of ~,-myeloma proteins, ~2A-myeloma 
proteins, ~,l-macroglobulins, and Bence Jones proteins identified  by two groups 
of common antigenic determinants, J. Clin. Inv., 1963, 42,811. 
9.  Mannik, M., and Kunkel, H. G., Two major types of normal 7S 7-globulin, 3.. Exp. 
Med., 1963,117, 213. 
10.  Fahey, J.  L., Two types of 6.6S "y-globulins, ~2A-globulins, and  18S ~,-tmacro- 
globulins in normal serum and ~'-microglobulins in normal urine, J. Immunol., 
1963, 91,438. 
11.  Bernier, G. M., and Cebra, J. J., Polypeptide chains of human gamma-globulin. 
cellular  localization  by fluorescent  antibody, Science, 1964, 144,  1590. 
12.  Mannik, M., and Kunkel, H. G., Localization of antibodies in group I and group 
II "y-globulins, J. Exp. Med.,  1963, 118, 817. 
13.  Franklin,  E.  C.,  and Fudenberg,  H. H., Antigenic  heterogeneity of human Rh 
antibodies, rheumatoid factors, and cold agglutinins, Arch. Bioct~m. and Bio- 
physics, 1964, 104, 433. 
14.  Kidd,  P.,  Elution  of an incomplete type of antibody from the erythrocytes in 
acquired haemolytic anaemia, J. CIin. Path., 1949, 2, 103. 16  HUMAN ERYTIIROCYTE AUTOANTIBODIES. I 
15.  Rosenfield, R. E., Allen, F. H., Jr., Swisher, S. N., and Kochwa, S., A review of 
Rh serology and presentation of a new terminology,  Transfusion,  1962, 2,287. 
16.  Edelman, G. M., and Gally, J. A., The nature of Bence-Jones proteins.  Chemical 
similarities to polypeptide chains of myeloma globulins and normal 7-giobulins, 
J. Exp. Med.,  1962, 116, 207. 
17.  Levy, H. B., and Sober, H. A., A simple chromatographic method for preparation 
of gamma globulin, Proc. Soc. Exp. Biol. and Med.,  1960, 103, 250. 
18.  Edelman, G. M., Heremans, J. F., Heremans, M.-Th., and Kunkel, H.  G.,  Im- 
munological  studies  of  human  "r-globulin. Relation of  the precipitin lines of 
whole ~,-giobulin to those of the fragments produced by papain, J. Exp. Ivied., 
1960, 112,203. 
19.  Franklin, E.  C.,  Structural units of human  7S gamma globulin,  J.  Clin.  Inv., 
1960, 39, 1933. 
20.  Fleischman, J. B., Porter, R. R., and Press, E. M., The arrangement of the pep- 
tide chains in "r-giobulin, Biochem. J., 1963, 88, 220. 
21.  Franklin, E. C., Meltzer, M., Guggenheim, F., and Lowenstein,  J., An unusual 
micro-gamma-globulin  in the serum  and urine of a patient, Fed. Proc., 1963, 
22,264. 
22. Leddy, J. P., Hill, R. W., Swisher, S. N., and Vaughan,  J. H., Observations  on 
the immunochemical nature of red cell autosensitization,  in Immunopathology, 
3rd International Symposium,  (P. Grabar and P. A. Miescher,  editors),  New 
York, Grune and Stratton,  1963, 318. 
23.  Ovary, Z.,  Immediate reactions in  the skin  of experimental animals  provoked 
by antibody-antigen interaction, Progr. Allergy, 1958, 5,459. 
24.  Pressman,  D.,  Campbell,  D. H.,  and Panling,  L., The agglutination  of intact 
azo-erythrocytes by antisera homologous to the attached groups, J. ImmunoI., 
1942, 44, 101; as modified by, Gordon, J., Rose, B., and Sehon, A. H., Detec- 
tion of "non-precipitating" antibodies in sera of individuals allergic to ragweed 
pollen by an in vitro method, J. Exp. Med.,  1958, 108, 37. 
25.  Leddy, J. P., Trabold, N. C., Vanghan,  J. H., and Swisher, S. N., The unitary 
nature of "complete" and "incomplete" pathologic cold hemaggiutinins,  Blood, 
1962, 19, 379. 
26.  Weiner, W., Reconstitution of frozen red cells, Lancet, 1961, 1, 1264. 
27.  Ouchterlony,  O., Diffusion-in-gel methods for immunological analysis.  II, Progr. 
Allergy, 1962, 6, 30. 
28.  Scheidegger,  J.  J.,  Une  micro-m~thode  de  l'immuno-~lectrophor~se,  Internat. 
Arch. Allergy and Appl. Immunol.,  1955, 7, 103. 
29.  Becker,  E.  L., Munoz, J.,  Lapresle,  C.,  and LeBean, L. J.,  Antigen-antibody 
reactions in  agar.  II.  Elementary theory and determination of diffusion co- 
efficients of antigen,  J. Immunot., 1951, 67, 501. 
30.  Rubinstein, H. M., Quantitative antigen analysis  by the Oudin method, J. Iw~ 
munol., 1954, 73,322. 
31.  Vaughan,  J. H. and Gray, B., data in preparation. 
32.  Race, R. R., and Sanger, R., Blood Groups in Man, Philadelphia,  F. A. Davis 
Co., 4th edition,  1962, 173ff. ]OHI~ P. LF.DDY  AND  RICHARD  ~F. BAKE~EIER  17 
33.  Weiner,  W., and Vos, G. H.,  Serology of acquired  hemolytic  anemias,  Blood, 
1963, 22,606. 
34.  Fahey, J. L., and Goodman, H., Antibody activity in six classes of human im- 
munoglobulins, Science, 1964, 143, 588. 
35. Barnett, E. V., Bakemeier, R. F., Leddy, J. P., and Vanghan,  J. H., Hetero- 
geneity of antinuclear factors in lupus erythematosus and rheumatoid arthritis, 
Arth. and Rl~umat., 1964, 7, 290 (abstract). 
36.  Harboe,  M., personal communication,  1964. 
37. Bumet, F. M., The Clonal Selection Theory of Acquired Immunity, Nashville, 
Vanderbilt  University Press,  1959, 128. 
38. Engle, R. L., Jr., and Nachman, R. L., Two Bence Jones proteins  of different 
immunologic groups in the same patient with multiple  myeloma, Abstracts of 
10th Congress of the International Society Haematol.,  Stockholm, 1964, D: 3. 
39. Schlossman, S. F., and Kabat, E. A., Specific fractionation  of a population  of 
antidextran molecules with combining sites  of various  sizes, J.  Exp.  Med., 
1962, 116, 535. 
40. Edelman,  G. M., and Kabat, E. A., Studies  on human antibodies. I.  Starch gel 
electrophoresis of the dissociated polypeptide  chains, Y. Exp. Med., 1964, 119, 
443. 